Identifies 15 mutations across EGFR, BRAF, KRAS genes.
Can detect mutations as low as 0.1% allele frequency.
Can utilise as low as 10ng input DNA.
Covers clinically relevant genomic alterations which enables physicians to personalize therapy for a patient.